PHYS 4_ platelets

Platelets; Endothelium-Platelet Relationship, and Hemostatic Mechanisms

Page 3: Hemostasis Overview

  • Hemostasis refers to the arrest of bleeding or prevention of blood loss after a blood vessel injury.

  • Achieved through interaction of vessel wall, circulating platelets, and plasma coagulation proteins.

  • Consequences of Imbalance:

    • Inadequate hemostasis leads to bleeding.

    • Excessive hemostasis results in inappropriate clotting (thrombosis).

Page 4: Hemostasis Events

  • Hemostasis mechanisms include:

    1. Vascular constriction.

    2. Formation of a platelet plug.

    3. Blood clot formation via coagulation.

    4. Fibrous tissue growth into the clot to permanently close vessel openings.

Page 5: Vascular Contraction Mechanisms

  • After vessel injury, smooth muscles in the wall contract, reducing blood flow.

  • Contraction mechanisms include:

    1. Local myogenic spasm.

    2. Autacoid factors from traumatized tissues and platelets.

    3. Nervous reflexes from sensory impulses from nearby tissues.

Page 6: Nervous Reflexes and Vasoconstriction

  • Vascular contraction occurs due to pain nerve impulses.

  • Increased vasoconstriction results from:

    • Local myogenic contraction.

    • Significantly traumatized vessels lead to more prolonged spasms.

    • Platelets release thromboxane A2, contributing to vasoconstriction.

Page 7: Formation of the Platelet Plug

  • Small blood vessel cuts may be sealed by a platelet plug instead of a full clot.

Page 8: Characteristics of Platelets

  • Platelets (thrombocytes) are 1 to 4 micrometers in diameter.

  • Formed from megakaryocytes in the bone marrow.

  • Normal platelet concentration: 150,000 to 450,000/μl.

  • Platelets have functional characteristics of whole cells despite lacking nuclei and reproduction ability.

Page 9: Cytoplasmic Components of Platelets

  • Platelet cytoplasm contains:

    1. Contractile proteins (actin, myosin, thrombosthenin).

    2. Endoplasmic reticulum and Golgi apparatus residues for enzyme synthesis and calcium storage.

    3. Mitochondria and systems for ATP and ADP production.

Page 10: Additional National Components of Platelets

  • Include: 4. Enzymes for prostaglandin synthesis (local hormone reactions). 5. Fibrin-stabilizing factor related to blood coagulation. 6. Growth factors for cellular growth aiding in vascular wall repair.

Page 11: Platelet Granule Contents

  • Alpha Granules:

    • von Willebrand factor, thrombospondin, platelet-derived growth factor (PDGF).

    • Platelet activating factor (PAF), fibrinogen, coagulation factors V and XI.

  • Dense Granules:

    • Serotonin, ADP, calcium, ATP.

Page 12: Platelet Membrane Surface Characteristics

  • Glycoproteins on the surface facilitate adhesion to injury sites and prevent adherence to healthy endothelium.

  • However, glycoprotein receptors help in adhesion and aggregation of platelets

  • Key receptors include:

    • Collagen, ADP, von Willebrand factor (vWF), and fibrinogen.

Page 13: Role of Platelet Surface Receptors

  • Various receptor functions:

    • Gp Ib-IX-V: mediates vWF-dependent adhesion.

    • Gp IIb/IIIa: binds fibrinogen for aggregation; receptor for vWF and fibronectin.

    • Gp Ia-IIa: for collagen adhesion.

Page 14: Platelet Properties

  • The membrane contains phospholipids functioning in the clotting process.

  • Platelet lifespan: 8 to 12 days; removed from circulation primarily by the spleen's macrophages.

Page 15: Platelet Unique Properties

  • Three critical properties:

    • Adhesion: to exposed vessel wall collagen.

    • Aggregation: sticking to one another, facilitated by fibrinogen and Gp IIb-IIIa.

    • Mechanisms promoting aggregation include thrombin, ADP, and PAF.

Page 16: Activation and Release of Platelets

  • Activated platelets change shape and become spherical, leading to aggregation via thrombin and ADP.

  • Shape change due to cytoskeletal reorganization and contraction of actomyosin filament.

Page 17: Chemical Factors in Platelet Function

  • Exposure to collagen initializes platelet activation and plug formation.

  • Several factors mediate adhesion and aggregation (e.g., thromboxane A2, ADP).

Page 18: Mechanisms for Platelet Plug Formation

  • Mechanisms for sealing vascular openings rely on:

    • Rapid adhesion upon contacting collagen and vWF.

    • Shape change and release of activating factors that promote aggregation.

Page 19: Mechanism Overview for Platelet Plug Formation

  • Platelets change in morphology and become sticky, allowing further aggregation leading to plug formation.

Page 20: Formation of Fibrin Threads

  • After initial platelet plug formation, blood coagulation leads to the development of fibrin threads that reinforce the plug.

Page 21: Role of Platelets in Blood Coagulation

  • At the site of injury, activated platelets attract more platelets, forming a temporary, loose plug until fibrin solidifies it.

Page 22: Endothelial Regulation

  • Endothelial cells prevent premature platelet activation by releasing nitric oxide and prostacyclin, increasing cGMP and cAMP levels.

  • Injury exposes collagen and vWF, facilitating platelet adherence and activation.

Page 23: Importance of Platelet Mechanism for Closing Vascular Holes

  • Platelets can fuse with endothelial cells to seal minute ruptures vertically.

Page 24: Blood Clot Formation

  • Blood clot formation commences quickly after vessel injury, initiated by various activators releasing from the injured site, leading to coagulation.

Page 25: Clot Follow-up

  • After approximately 20-60 minutes, the clot retracts, consolidating the healing area.

Page 26: Fibrous Organization of Blood Clots

  • Clots can either:

    1. Be invaded by fibroblasts forming connective tissue.

    2. Dissolve over time via enzymatic action ( plasmin).

Page 27: Growth Factor Role in Clot Organization

  • Growth factors from platelets promote fibroblast invasion to facilitate tissue repair.

Page 28: Blood Coagulation Mechanism General Overview

  • More than 50 substances affect coagulation balances: procoagulants favoring clotting and anticoagulants inhibiting it.

Page 29: Clotting Factors

  • Factors involved in coagulation include prothrombin, fibrinogen and multiple others (see comprehensive table).

Page 30: Steps in Blood Coagulation

  1. Formation of prothrombin activator following vascular damage.

  2. Prothrombin is converted into thrombin.

  3. Thrombin converts fibrinogen into fibrin forming the actual clot.

Page 31: Prothrombin to Thrombin Conversion

  • Requires prothrombin activator and calcium.

Page 32: Thrombin Action on Fibrinogen

  • Thrombin facilitates rapid polymerization of fibrinogen into fibrin, leading to clot formation.

Page 33: Prothrombin Details

  • Prothrombin is continuously synthesized by the liver; a deficiency results in bleeding tendency.

Page 34: Vitamin K Dependency

  • Essential for prothrombin activation and several clotting factors; deficiency leads to bleeding risks.

Page 35: Fibrinogen Role in Clot Formation

  • High molecular weight protein essential in coagulation; can leak into tissues under certain conditions.

Page 36: Thrombin on Fibrinogen

  • Converts fibrinogen to fibrin, initiating clot formation; early fibrin networks are weak.

Page 37: Fibrin Stabilizing Factor Activation

  • Fibrin stabilizing factor incorporates into forming clots, enhancing strength through cross-linked bonds.

Page 38: Composition of Blood Clot

  • A meshwork of fibrin fibers containing blood cells and platelets stabilizing the structure against leaks.

Page 39: Clot Retraction and Serum Expression

  • Clot retracts, expressing fluid called serum, which lacks clotting factors. Platelets play a critical role in this process.

Page 40: Platelet Contributions to Clot Stability

  • Platelets allow further cross-linking of fibrin fibers and enhance clot strength.

Page 41: Positive Feedback Mechanism of Clotting

  • Initial clot formation enhances subsequent clotting through thrombin's actions on other factors.

Page 42: Initiation of Coagulation

  • Involves trauma to tissue or blood, leading to prothrombin activator formation.

Page 43: Pathways for Prothrombin Activator Formation

  • Clotting occurs via intrinsic or extrinsic pathways, constantly interacting.

Page 44: Extrinsic Pathway Initiation

  • Starts with a tissue injury, releasing tissue factor.

Page 45: Steps in the Extrinsic Pathway

  1. Tissue factor release.

  2. Activation of factor X via factor VII and tissue factor interaction.

Page 46: Role of Factor X in Coagulation

  • Activated factor X creates prothrombin activator; thrombin is then generated.

Page 47: Positive Feedback Impact of Thrombin

  • Initiated clotting rapidly accelerates rate of clot formation and factor activation.

Page 48: Intrinsic Pathway Initiation

  • Triggered through blood damage and collagen exposure; cascades result in prothrombin activator formation.

Page 49: Early Intrinsic Pathway Steps

  • Activates factor XII and platelet phospholipids after trauma.

Page 50: Activation of Factor XI

  • Factor XI activated by factor XII, moving forward in the cascade.

Page 51: Further Intrinsic Pathway Actions

  • Factor IX activated for subsequent generation of factor X by factors VIII and platelet phospholipids.

Page 52: Common Pathway of Clotting Mechanisms

  • Similar actions as in extrinsic pathway lead to prothrombin activation and then thrombin production.

Page 53: Calcium Ions in Coagulation

  • Essential for all reactive steps in blood clotting cascades beyond the initial factors.

Page 54: Simultaneous Activation of Pathways

  • Extrinsic pathways can lead to rapid clotting, while intrinsic pathways are slower but equally important.

Page 55: Endothelial Surface Factors

  • Significance: Smooth surfaces prevent clotting; glycocalyx and thrombomodulin play crucial roles in anticoagulation.

Page 56: Anticoagulant Functions of Endothelial Cells

  • Maintains blood flow and prevents clotting through various mechanisms, including factor regulation.

Page 57: Thrombomodulin Role in Clot Control

  • Thrombomodulin binds thrombin, inactivating factors for anticoagulation regulation.

Page 58: Damaged Endothelium and Clotting Activation

  • Loss of endothelial integrity accelerates intrinsic pathway activation resulting in clot formation.

Page 59: Endothelial Production of Inhibitory Factors

  • Post-injury reduction in release factors like prostacyclin and NO leads to platelet aggregation.

Page 60: Antithrombin III and Fibrin Action

  • Vital in removing thrombin during clotting; includes factors that enhance anticoagulation and stability.

Page 61: Fibrin Fiber Adsorption of Thrombin

  • Adsorbed thrombin prevents excessive clotting; regulates thrombin activity after clot formation.

Page 62: Heparin's Role in Blood Anticoagulation

  • Heparin functions as a powerful anticoagulant, enhancing the activity of antithrombin III significantly.

Page 63: Heparin Mechanism Interaction

  • Interaction with antithrombin further promotes rapid removal of activated coagulation factors.

Page 64: Role of Mast Cells in Heparin Production

  • Heparin is produced by various cells, preventing thrombus formation especially in the lungs and liver.

Page 65: Plasmin's Role in Clot Dissolution

  • Plasminogen is converted to plasmin in tissue healing, enabling clot lysis.

Page 66: Mechanism of Plasmin Activation

  • Plasminogen trapped in clots when activated, enabling gradual tissue recovery and vessel reopening.

Page 67: Summary of Fibrinolytic Pathway

  • Fibrinolysis occurs post-clotting, crucial for maintaining blood flow in microvessels.

Page 68: Fibrin Degradation Products

  • Breakdown of fibrin leads to smaller fragments measurable in blood work for clotting assessment.

Page 69: Protein C and Fibrinolysis Regulation

  • Activated protein C plays a crucial role in regulating fibrinolysis and maintaining hemostatic balance.

Page 70: Blood Coagulation Conditions

  • Multiple deficiencies can lead to excessive bleeding, particularly relevant in vitamin K and specific coagulation factors.

Page 71: Conditions Causing Excessive Bleeding

  • Common causes: vitamin K deficiency, hemophilia, and thrombocytopenia, leading to bleeding disorders.

Page 72: Vitamin K Deficiency Overview

  • Associated with liver disease and can lead to elevated bleeding risks due to reduced coagulation factor production.

Page 73: Hemophilia Overview

  • Genetic condition affecting males, most commonly due to factor VIII deficiency leading to clotting impairment.

Page 74: Thrombocytopenia Defined

  • Results from low platelet counts; important in managing small vessel bleedings and total body hemorrhage risks.

Page 75: Diagnosing Thrombocytopenia

  • Low platelet count correlates with risk levels and affects surgery outcomes.

Page 76: Blood Coagulation Proficiency Tests

  • Measurement techniques for bleeding time, clotting time, and INR standards to assess coagulation status.

Page 77: Bleeding and Clotting Time Tests

  • Essential tests in identifying disorders related to coagulation factor deficiencies.

Page 78: Prothrombin Time Measurement

  • Prothrombin time indicates factors status in clotting; measured using specific laboratory procedures.

Page 79: International Normalized Ratio (INR)

  • Standardizes prothrombin time results for consistent assessment regardless of testing methods.

Page 80: Functionality of Other Clotting Factor Tests

  • Key tests assess concentrations of other clotting factors, assuring proper hemostatic responses.

Page 81: Primary Hemostasis Mechanisms

  • Initial responses to injury involve primary platelet plug formation crucial for vascular integrity.

Page 82: Secondary Hemostasis Formation

  • Continues the coagulation response, completing vascular repair mechanisms and stabilizing the initial plug.

Page 83: Thrombin Action and Fibrin Formation

  • Functions in secondary hemostasis include thrombin actions on fibrinogen generating fibrin for clot stabilization.

Page 84: Summary of Hemostasis Mechanisms

  • Overall processes involve a delicate balance of factors ensuring efficient clot structure and prevention of bleeding.